Kesavadev J - Search Results

1

Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.

Ghosh S, Unnikrishnan AG, Saboo B, Kesavadev J, Aravind SR, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A, Makkar BM, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar TKM, Maheshwari A, Pendsey S, Phatak SR, Sharma SK, Singh SK, Ramachandran A, Zargar AH, Joshi SR, Sadikot SM. Ghosh S, et al. Among authors: kesavadev j. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S507-S521. doi: 10.1016/j.dsx.2017.03.045. Epub 2017 Apr 5. Diabetes Metab Syndr. 2017. PMID: 28433618 Review.

2

Use of insulin pumps in India: suggested guidelines based on experience and cultural differences.

Kesavadev J, Das AK, Unnikrishnan R 1st, Joshi SR, Ramachandran A, Shamsudeen J, Krishnan G, Jothydev S, Mohan V. Kesavadev J, et al. Diabetes Technol Ther. 2010 Oct;12(10):823-31. doi: 10.1089/dia.2010.0027. Diabetes Technol Ther. 2010. PMID: 20807118 Free PMC article.

3

Continuous insulin infusion systems in type 2 diabetes.

Kesavadev J. Kesavadev J. J Assoc Physicians India. 2011 Apr;59 Suppl:41-3. J Assoc Physicians India. 2011. PMID: 21818997

4

Suggested use of vaccines in diabetes.

Kesavadev J, Misra A, Das AK, Saboo B, Basu D, Thomas N, Joshi SR, Unnikrishnan AG, Shankar A, Krishnan G, Unnikrishnan R, Mohan V. Kesavadev J, et al. Indian J Endocrinol Metab. 2012 Nov;16(6):886-93. doi: 10.4103/2230-8210.102982. Indian J Endocrinol Metab. 2012. PMID: 23226631 Free PMC article.

5

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes.

Meneghini L, Kesavadev J, Demissie M, Nazeri A, Hollander P. Meneghini L, et al. Among authors: kesavadev j. Diabetes Obes Metab. 2013 Aug;15(8):729-36. doi: 10.1111/dom.12083. Epub 2013 Mar 13. Diabetes Obes Metab. 2013. PMID: 23421331 Clinical Trial.

6

Barriers and solutions to diabetes management: An Indian perspective.

Wangnoo SK, Maji D, Das AK, Rao PV, Moses A, Sethi B, Unnikrishnan AG, Kalra S, Balaji V, Bantwal G, Kesavadev J, Jain SM, Dharmalingam M. Wangnoo SK, et al. Among authors: kesavadev j. Indian J Endocrinol Metab. 2013 Jul;17(4):594-601. doi: 10.4103/2230-8210.113749. Indian J Endocrinol Metab. 2013. PMID: 23961474 Free PMC article.

7

Improvement of glycemic control with addition of insulin detemir to existing antidiabetic therapy: a sub-group analysis of A1chieve observational study.

Kesavadev J, Joshi SR. Kesavadev J, et al. J Assoc Physicians India. 2013 Jan;61(1 Suppl):28-30. J Assoc Physicians India. 2013. PMID: 24482985

8

Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM.

Kesavadev J, Sadikot S, Wangnoo S, Kannampilly J, Saboo B, Aravind SR, Kalra S, Makkar BM, Maji D, Saikia M, Anjana RM, Rajput R, Singh SK, Shah S, Dhruv U, Vishwanathan V. Kesavadev J, et al. Diabetes Metab Syndr. 2014 Jul-Sep;8(3):187-95. doi: 10.1016/j.dsx.2014.04.030. Epub 2014 May 28. Diabetes Metab Syndr. 2014. PMID: 25200925

9

Challenges in Type 1 diabetes management in South East Asia: Descriptive situational assessment.

Kesavadev J, Sadikot SM, Saboo B, Shrestha D, Jawad F, Azad K, Wijesuriya MA, Latt TS, Kalra S. Kesavadev J, et al. Indian J Endocrinol Metab. 2014 Sep;18(5):600-7. doi: 10.4103/2230-8210.139210. Indian J Endocrinol Metab. 2014. PMID: 25285274 Free PMC article. Review.

10

Understanding the safety of the new ultra long acting basal insulin.

Ramachandran A, Gupta V, Kesavadev J, Kalra S. Ramachandran A, et al. Among authors: kesavadev j. J Assoc Physicians India. 2014 Jan;62(1 Suppl):35-42. J Assoc Physicians India. 2014. PMID: 25330630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page